Alteryx, Inc. (NYSE:AYX) Expected to Announce Quarterly Sales of $160.90 Million

Brokerages expect Alteryx, Inc. (NYSE:AYXGet Rating) to announce sales of $160.90 million for the current quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Alteryx’s earnings, with the highest sales estimate coming in at $161.90 million and the lowest estimate coming in at $160.30 million. Alteryx reported sales of $120.07 million during the same quarter last year, which indicates a positive year over year growth rate of 34%. The business is scheduled to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Alteryx will report full year sales of $735.72 million for the current fiscal year, with estimates ranging from $734.20 million to $739.10 million. For the next financial year, analysts expect that the business will report sales of $867.57 million, with estimates ranging from $809.98 million to $908.00 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that cover Alteryx.

Alteryx (NYSE:AYXGet Rating) last issued its earnings results on Tuesday, May 3rd. The company reported ($0.40) earnings per share for the quarter, beating the consensus estimate of ($0.59) by $0.19. The firm had revenue of $157.94 million for the quarter, compared to analysts’ expectations of $145.88 million. Alteryx had a negative net margin of 42.51% and a negative return on equity of 46.53%. The firm’s revenue was up 33.0% compared to the same quarter last year. During the same quarter last year, the company earned ($0.45) earnings per share.

A number of analysts have weighed in on the stock. JPMorgan Chase & Co. raised their price objective on shares of Alteryx from $65.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, February 16th. Needham & Company LLC lifted their price objective on shares of Alteryx from $66.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, April 1st. Berenberg Bank began coverage on Alteryx in a research note on Thursday, January 27th. They set a “buy” rating and a $66.00 price target for the company. Bank of America downgraded shares of Alteryx from a “buy” rating to a “neutral” rating and cut their target price for the company from $84.00 to $65.00 in a research note on Tuesday, February 1st. Finally, Rosenblatt Securities decreased their target price on Alteryx from $100.00 to $87.00 and set a “buy” rating for the company in a report on Wednesday, February 16th. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $86.86.

NYSE:AYX traded down $1.60 during mid-day trading on Friday, hitting $54.60. The stock had a trading volume of 7,101 shares, compared to its average volume of 853,523. The stock has a 50-day simple moving average of $66.29 and a two-hundred day simple moving average of $63.26. The company has a market capitalization of $3.72 billion, a PE ratio of -15.48 and a beta of 0.72. Alteryx has a twelve month low of $49.67 and a twelve month high of $90.57. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 3.43.

In other news, Director Timothy I. Maudlin sold 9,233 shares of the firm’s stock in a transaction dated Friday, February 18th. The stock was sold at an average price of $55.75, for a total transaction of $514,739.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeff Horing purchased 320,601 shares of the business’s stock in a transaction dated Tuesday, February 22nd. The shares were purchased at an average cost of $54.69 per share, with a total value of $17,533,668.69. The disclosure for this purchase can be found here. 13.84% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Ancora Advisors LLC purchased a new stake in shares of Alteryx during the 1st quarter worth about $29,000. Ahrens Investment Partners LLC acquired a new stake in Alteryx in the 4th quarter valued at approximately $30,000. Retirement Planning Co of New England Inc. acquired a new stake in Alteryx in the 4th quarter valued at approximately $30,000. Signaturefd LLC grew its holdings in Alteryx by 54.8% in the 1st quarter. Signaturefd LLC now owns 565 shares of the company’s stock valued at $40,000 after buying an additional 200 shares during the last quarter. Finally, Allworth Financial LP grew its holdings in Alteryx by 798.7% in the 1st quarter. Allworth Financial LP now owns 674 shares of the company’s stock valued at $48,000 after buying an additional 599 shares during the last quarter. 71.04% of the stock is owned by institutional investors.

About Alteryx (Get Rating)

Alteryx, Inc provides end-to-end analytics platform for data analysts and scientists worldwide. Its analytic process automation software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.

Read More

Get a free copy of the Zacks research report on Alteryx (AYX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.